BIOMx: Funding, Investors & Team (Sep 2026)
In order to target and eliminate bacteria that harm the skin's look as well as dangerous bacteria in chronic conditions such cystic fibrosis, inflammatory bowel disease, atopic dermatitis, and colorectal cancer, BiomX is developing both natural and manufactured phage cocktails. In order to attack specific bacterial targets, BiomX develops and certifies its own phage compositions.
BIOMx has raised $90.5M across 6 funding rounds on record, the most recent an undisclosed round of $3.0M announced in Dec 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BIOMx Company Profile and Key Stats
Latest funding round on record: Dec 2025.
BIOMx Funding Rounds
BIOMx raised $15.0M in a Post-IPO Equity announced in Jul 2021.
6 months later, a Post-IPO Equity of $3.0M was announced in Jan 2022.
1.1 years later, an undisclosed round of $7.5M was announced in Feb 2023.
1.1 years later, an undisclosed round of $50.0M was announced in Mar 2024.
11 months later, an undisclosed round of $12.0M was announced in Feb 2025.
10 months later, an undisclosed round of $3.0M was announced in Dec 2025.
BIOMx Founders and Leadership Team
Contact details for the BIOMx team: 1 of 2 have an email address on file.
Start 14-day free trial →BIOMx Funding Compared to Other Biotechnology Startups
BIOMx's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BIOMx in Biotechnology and Ness Ziona
Companies Similar to BIOMx
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
BIOMx Funding FAQs
What does BIOMx do?
In order to target and eliminate bacteria that harm the skin's look as well as dangerous bacteria in chronic conditions such cystic fibrosis, inflammatory bowel disease, atopic dermatitis, and colorectal cancer, BiomX is developing both natural and manufactured phage cocktails. In order to attack specific bacterial targets, BiomX develops and certifies its own phage compositions.
How much funding has BIOMx raised?
BIOMx has raised $90.5M across 6 rounds on record. The most recent is an undisclosed round of $3.0M announced in Dec 2025.
When did BIOMx last raise funding?
BIOMx's most recent funding round on record is an undisclosed round of $3.0M, announced in Dec 2025.
Who founded BIOMx?
FundedIQ lists Eran Elinav (Founder) at BIOMx.
Who is the CEO of BIOMx?
Jonathan Solomon is listed as CEO at BIOMx.
Where is BIOMx headquartered?
BIOMx is based in Ness Ziona, Hamerkaz, Israel.
How many employees does BIOMx have?
BIOMx is in the 51-100 employee band.
How does BIOMx's funding compare to other Biotechnology startups?
BIOMx's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's BIOMx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BIOMx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.